HIGHLIGHTS
- who: Giuseppe Fasolino and colleagues from the the Declaration of Helsinki and was approved by the ethical committee of the University Hospital of BrusselsAll included patients signed for written informed consent. Table , features a complete list of patient characteristics. Table, . Clinical baseline characteristics. Patient (Eyes) have published the research: Assessment of Retinal Pigment Epithelium Alterations and Chorioretinal Vascular Network Analyses in Patients under Treatment with BRAF/MEK Inhibitor for Different Malignancies: A Pilot Study, in the Journal: (JOURNAL)
- what: This study aims to assess the presence of retinal pigment as predictive parameters for retinal toxicity . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.